Telomir Pharmaceuticals, Inc. Common StockTELONASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
80.00%
↑ 199% above average
Average (14q)
-80.97%
Historical baseline
Range
High:80.00%
Low:-453.63%
Volatility
-659.0%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 80.00% |
| Q2 2025 | -132.24% |
| Q1 2025 | 25.31% |
| Q4 2024 | 51.00% |
| Q3 2024 | -309.00% |
| Q2 2024 | 78.74% |
| Q1 2024 | 28.13% |
| Q4 2023 | -453.63% |
| Q3 2023 | -10.31% |
| Q2 2023 | -221.47% |
| Q1 2023 | 1.21% |
| Q4 2022 | -108.86% |
| Q3 2022 | -229.17% |
| Q2 2022 | -14.29% |
| Q1 2022 | 0.00% |